Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 13 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16 Carcinoma, Hepatocellular 11 Stomach Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Myositis 2 Lung Neoplasms 2 Cholangiocarcinoma 2 Vascular Complications 1 Sjogren's Syndrome 1 Scleroderma, Systemic 1 Sarcopenia 1 Recurrence 1 Rectal Neoplasms 1 Plaque, Atherosclerotic 1 Pathologic Complete Response 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Metastatic Colorectal Adenocarcinoma 1 Melanoma 1 Lupus Erythematosus, Systemic 1 Lung Diseases, Interstitial 1 Liver Neoplasms 1 Influenza, Human 1 Immune-Related Adverse Events 1

Interventions

Blood Specimen Collection 7 Drug Therapy 6 Surveys and Questionnaires 5 Radiotherapy 5 Radiosurgery 5 Docetaxel 5 Therapeutics 4 Specimen Handling 4 Immunotherapy 4 Hepatectomy 4 exemestane 3 enzalutamide 3 apalutamide 3 Trastuzumab 3 Hematologic Tests 3 Data Collection 3 Biopsy 3 Biological Assay 3 Anastrozole 3 Abiraterone Acetate 3 trastuzumab deruxtecan 2 palbociclib 2 darolutamide 2 abiraterone 2 abemaciclib 2 Wearable Electronic Devices 2 Triptorelin Pamoate 2 Tamoxifen 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm Metastasis × Immune Checkpoint Inhibitors × Clear all

NCT03868046 2025-04-01

AUTENTIC

Hospital Universitario Araba

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡